Man Accused of Secretly Drugging Pregnant Partner

A 25-year-old man from the Houston suburbs has been charged after investigators said he secretly gave his pregnant girlfriend abortion medication without her knowledge, leading to a pregnancy loss and the delivery of a stillborn baby at a hospital in The Woodlands.

The case has drawn attention because it centers on an allegation of hidden drugging inside an intimate relationship and because it involves medication that is tightly restricted in Texas. Investigators have described it as a family violence case and said additional charges could be considered as evidence is processed and medical findings are reviewed.

Deputies with the Montgomery County Sheriff’s Office were called to the hospital on Sat., Feb. 21, 2026, after staff reported what authorities described as a miscarriage under suspicious circumstances. The woman told investigators she believed the father of her baby had administered a drug intended to end the pregnancy without her consent, authorities said. Sheriff Wesley Doolittle said the report was treated as a major crimes investigation because it involved allegations of domestic violence and serious bodily injury.

On Mon., Feb. 23, 2026, investigators said the suspect, Jon Rueben Gabriel Demeter of Spring, was charged with aggravated assault with a deadly weapon causing serious bodily injury in a family violence case. Authorities said Demeter was booked into the Montgomery County Jail and held without bond as the investigation continued. Officials have not released key details about how the medication was given, when it was administered, or where the alleged drugging occurred, saying evidence was still being processed.

Investigators said the woman told them she planned to carry the pregnancy to term, while Demeter wanted her to have an abortion and tried more than once to persuade her. Authorities said she reported that he offered to pay for her to travel out of state for an abortion. Investigators allege that instead, he obtained abortion medication and covertly administered it without her knowledge or consent. The sheriff’s office said the baby was delivered stillborn at the hospital, and the mother named the child Presley Mae.

Authorities have not said how far along the pregnancy was, and they have not publicly described the medical findings that led investigators to focus on abortion medication. Officials also have not said whether investigators recovered pills, packaging, electronic records, or other items that could show how the medication was obtained. They have said the central allegation is that the medication was administered without consent and with the intent to end the pregnancy.

The sheriff’s office said the investigation involved detectives in the Major Crimes Unit working with the Montgomery County District Attorney’s Office, along with crime scene investigators and assistance from the Montgomery County Medical Examiner’s Office. That type of coordination is common when investigators anticipate the need for medical records, toxicology or other lab work, and a tight timeline that prosecutors can present in court.

Demeter’s family has publicly suggested the case is more complicated than early public accounts reflect, while not directly addressing the allegation that medication was given without consent. In an interview with a Houston-area television station, his mother, Cookie Demeter, said her son turned himself in and that his side would come out in court. “You don’t know the other side of the story,” she said. She also said her son has two young children and that she had only recently learned about the pregnancy.

Authorities have not released the woman’s name, a common practice in cases involving alleged domestic violence and sensitive medical information. Officials have not said whether there were prior police calls involving the couple or whether investigators are examining a broader pattern of coercion beyond the reported pressure to end the pregnancy. They also have not said what kinds of records they have sought, such as phone messages, payments, shipping information, or other communications that could help establish intent and timing.

The wording of the charge has also drawn notice. In Texas, prosecutors can treat an object or substance as a “deadly weapon” if they allege it was used in a way capable of causing serious bodily injury or death. In this case, the alleged abortion medication is described in charging language as the deadly weapon. The label is a legal classification used in some cases involving drugs or other substances when investigators allege severe harm resulted from their use, and the claim must ultimately be tested in court.

Officials have framed the investigation as a domestic violence case rather than a dispute over a medical choice. Even so, the allegation sits within a broader legal landscape in Texas where abortion is heavily restricted and access to medication used in abortions is closely regulated. Investigators have not publicly explained how they believe the medication was acquired, whether they suspect it was ordered, obtained through another person, or acquired in another way. They have also not said whether they are investigating anyone else in connection with obtaining the medication.

Some early reporting has identified the medication investigators believe may be involved as mifepristone, which blocks a hormone needed to continue a pregnancy and is often used with a second drug in medication abortions. Authorities have not publicly described any lab results or testing that would confirm a specific drug, and they have not said whether toxicology findings are pending. In cases involving suspected covert administration of medication, investigators often rely on medical timing, laboratory work, and small pieces of evidence such as messages, receipts, or the recovery of pills or packaging.

What remains unclear is the timeline between the alleged administration and the hospital visit, along with what the woman may have experienced before she sought care. Officials have not said whether investigators believe the medication was mixed into food or a drink, taken in pill form, or administered in another way. They have not said whether any witnesses were present or whether surveillance video exists from locations that could help confirm movements or purchases tied to the case.

For prosecutors, the criminal case is likely to hinge on whether investigators can tie a specific medication to a specific act by a specific person, and whether they can show intent beyond a reasonable doubt. The sheriff’s office has said the charge could be enhanced as the investigation continues, but officials have not explained what changes are being considered or what evidence would trigger them. Charging decisions can shift as medical findings are finalized and as prosecutors weigh how best to present the evidence to a judge or jury.

Demeter’s first court appearances are expected to address standard early issues such as counsel, bond status, and any conditions of release, though officials have said he remained jailed without bond. Court records, probable cause documents, and any future filings are likely to provide a clearer picture of what investigators say they have recovered and what they still need to confirm. In the meantime, the case remains in an early stage, with authorities emphasizing that evidence processing and investigative work are ongoing.

As of Thu., Feb. 26, 2026, Demeter remained held in the Montgomery County Jail without bond, and investigators said they were still processing evidence. The next major milestones are expected to come through court hearings and prosecutorial decisions on whether to keep the current charge or seek additional counts once medical and investigative findings are complete.

Author note: Last updated February 26, 2026.